Literature DB >> 4204730

New, third class of amyloid fibril protein.

G Husby, J B Natvig, K Sletten.   

Abstract

An unusual protein AR was isolated from the amyloid fibril preparation derived from a patient with primary amyloidosis. Protein AR was unique in its antigenicity, and revealed no structural identity with any known amyloid proteins or with immunoglobulin chains or fragments. Thus a new third class of amyloid fibril proteins besides the immunoglobulin light-chain variable region fragments and the nonimmunoglobulin protein AS, has been characterized. A component antigenically related to protein AR was found in the serum of the patient.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4204730      PMCID: PMC2139555          DOI: 10.1084/jem.139.3.773

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences.

Authors:  E P. Benditt; N Eriksen; M A. Hermodson; L H. Ericsson
Journal:  FEBS Lett       Date:  1971-12-01       Impact factor: 4.124

2.  Amino acid sequence of a kappa Bence Jones protein from a case of primary amyloidosis.

Authors:  F W Putnam; E J Whitley; C Paul; J N Davidson
Journal:  Biochemistry       Date:  1973-09-11       Impact factor: 3.162

3.  Unique amyloid protein subunit common to different types of amyloid fibril.

Authors:  G Husby; J B Natvig; T E Michaelsen; K Sletten; H Höst
Journal:  Nature       Date:  1973-08-10       Impact factor: 49.962

4.  Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses.

Authors:  G G Glenner; W Terry; M Harada; C Isersky; D Page
Journal:  Science       Date:  1971-06-11       Impact factor: 47.728

5.  The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis.

Authors:  K Sletten; G Husby
Journal:  Eur J Biochem       Date:  1974-01-03

6.  Antigenic and chemical characterization of non-immunoglobulin amyloid proteins.

Authors:  G Husby; K Sletten; T E Michaelsen; J B Natvig
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

7.  Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia.

Authors:  G Husby; K Sletten; T E Michaelsen; J B Natvig
Journal:  Scand J Immunol       Date:  1973       Impact factor: 3.487

8.  The characterization of soluble amyloid prepared in water.

Authors:  M Pras; M Schubert; D Zucker-Franklin; A Rimon; E C Franklin
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

9.  Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component.

Authors:  M Levin; M Pras; E C Franklin
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

  9 in total
  8 in total

1.  Acceleration of amyloidosis by syngeneic spleen cells from normal donors.

Authors:  M Axelrad; R Kisilevsky; S Beswetherick
Journal:  Am J Pathol       Date:  1975-02       Impact factor: 4.307

2.  Editorial: Newer concepts in amyloidogenesis.

Authors:  A Katz; W Pruzanski
Journal:  Can Med Assoc J       Date:  1976-05-22       Impact factor: 8.262

3.  Comparative studies of the high molecular weight amyloid fibril proteins and similar components from normal tissues.

Authors:  D L Scott; G Marhaug; G Husby
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

4.  The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR.

Authors:  K Sletten; J B Natvig; G Husby; J Juul
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

5.  Experimental murine amyloidosis: a model system for studying amyloid formation.

Authors:  R Baumal; B Wilson; E Pass
Journal:  Can Med Assoc J       Date:  1975-09-20       Impact factor: 8.262

6.  Clinical and laboratory findings in primary generalized and multiple-myeloma-related amyloidosis.

Authors:  W Pruzanski; A Katz
Journal:  Can Med Assoc J       Date:  1976-05-22       Impact factor: 8.262

7.  Amyloid fibril protein AA in Papua New Guinean amyloidosis.

Authors:  R F Anders; M A Price; I S Wilkey; G Husby; F Takitaki; J B Natvig; K P McAdam
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

8.  Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid.

Authors:  K Sletten; P Westermark; J B Natvig
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.